$HBIO 3 SEC Filings

Filed On	Filing
30 Dec 2025	Form 3: Snider William, Director
07 Oct 2025	Form 3: Denelsky Stephen J, Director No securities owned
25 Jul 2025	Form 3: Benson Seth Benjamin, Director No securities owned
18 Jul 2025	Form 3: Gagnon Robert E., Director No securities owned
09 Jun 2025	Form 3: Duke John D, Director No securities owned
14 May 2025	Form 3: Frost Mark T, Interim CFO Holds 25,000 shares of Common Stock
03 Jan 2023	Form 3: Cote Jennifer, Interim CFO Holds 30,334 shares of Common Stock
08 Apr 2020	Form 3: Steele Susan M., Director No securities owned
06 Nov 2019	Form 3: Olson Kenneth Fletcher, Vice President No securities owned
05 Nov 2019	Form 3: Singh Yash, Executive Vice President No securities owned
05 Sep 2019	Form 3: Edrick Alan I, Director Holds 25,400 shares of Common Stock
30 Jul 2019	Form 3: Rossi Michael A., Chief Financial Officer No securities owned
27 Nov 2018	Form 3: Unninayar Kamalam, Chief Financial Officer No securities owned
01 Nov 2017	Form 3: Eade Katherine A., Director No securities owned
01 Nov 2017	Form 3: Loewald Thomas W, Director No securities owned
30 Apr 2015	Form 3: Green James W, Director Holds 2,000 shares of Common Stock
10 Nov 2014	Form 3: Loy Bertrand, Director No securities owned
18 Nov 2013	Form 3: Sun Yong, VP - Strategic Marketing No securities owned
18 Nov 2013	Form 3: Sibony Yoav, VP - Global Sales No securities owned
21 Oct 2013	Form 3: Harvard Bioscience Inc, 10% owner · Harvard Apparatus Regenerative Technology Inc Holds 8,000,000 shares of Common Stock, par value $0.01 per share

Comments